Based on data on the use of PPI class drugs for the last 6 months, at December 2020-May 2021 at RSUDZA, the PPI drug class is among the drugs that are widely used every year, it is also prescribed for use other than cases of gastric acid secretion disorders and hematemesis melena, it can have an impact on optimization of drug spending costs so that if the hospital cannot control the drug spending budget and it can have an impact on the hospital's cash flow. This study aims to analyze the cost minimization of PPI (proton pump inhibitor) therapy in surgical inpatients at RSUD dr. Zainoel Abidin uses a restriction form. This study is an analytical intervention study with a prospective method and based on inclusion criteria by looking at the medical records of inpatients Neurosurgery and Orthopedics in Raudhah 3,4, and 5 by filling out the research tool used is the request sheet for restriction drugs of the PPI (Proton Pump Inhibitor) class., data collection was carried out from July-October 2021 using purposive sampling. The cost analysis used in this study is CMA (Cost Minimization Analysis), Chi-Square test to see the effect between two groups of variables, Kolmogorov Smirnove normality test to analyze data normality, and Mann Whitney to see the mean difference between groups pretest-posttest. The results showed that the use of PPI therapy in this study mostly used Omeprazole 40 mg iv therapy is 98%. There was an effect of giving a PPI restriction form to decrease the frequency of using Omeprazole 40 mg iv to every 24 hours for prophylactic statistically (p<0.000). Analysis of the cost of CMA in neurosurgery patients found that there was no decrease in the cost of Omeprazole 40 mg iv therapy in the restriction form treatment group, analysis of the cost of CMA in orthopedic surgery patients found a decrease in the cost of Omeprazole 40 mg iv therapy in the treatment group using the restriction form. Factors that influence the cost analysis in this study are length of stay, types of other drug items obtained during treatment, type of surgery, and duration of use of PPI class therapy.
Penelitian ini bertujuan untuk mengevaluasi rasionalitas pemberian Human Serum Albumin (HSA), hubungan pemberian HSA dengan capaian kadar serum albumin pasca transfusi, dan faktor-faktor yang mempengaruhi perubahan kadar serum albumin pada pasien rawat inap bedah Digestif RSUD dr Zainoel Abidin. Penelitian ini merupakan penelitian survei analitik dengan pengambilan data dilakukan secara prospektif dan berdasarkan kriteria inklusi dan eksklusi terhadap penggunaan HSA. Data dianalisis dari rekam medis pasien bedah digestif periode Mei–Agustus 2019. Evaluasi rasionalitas penggunaan HSA berdasarkan perhitungan koreksi albumin menggunakan pedoman Recommendations for the use of albumin and immunoglobulins (2009). Analisis Data karakteristik demografi menggunakan statistik Fisher dan Kolmogorov-smirnov, dan analisis hubungan menggunakan Spearman’s rho. Hasil penelitian pada 30 rekam medik pasien didapatkan tidak ada pengaruh signifikan ( p>0,05) pada faktor jenis kelamin, usia, Indeks Massa Tubuh (IMT), jumlah komorbid, dan asupan protein, persentase rasionalitas pemberian infus albumin pada bedah digestif adalah 10% rasional dan 90% tidak rasional, tidak terdapat korelasi antara pemberian HSA terhadap capaian kadar serum albumin (p>0,05). Dapat disimpulkan bahwa karakteristik demografi tidak berpengaruh terhadap perubahan serum albumin, rasionalitas pemberian HSA berdasarkan pedoman perhitungan koreksi albumin terdapat 10% rasional dan 90% tidak rasional, serta tidak terdapat korelasi pemberian HSA dengan capaian kadar serum albumin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.